Canada markets closed

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.42-0.19 (-2.87%)
At close: 04:00PM EDT
6.45 +0.03 (+0.47%)
After hours: 07:57PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.44B
Enterprise Value 5.00B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.11k
Price/Book (mrq)N/A
Enterprise Value/Revenue 16.56k
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.23
52-Week Change 3130.11%
S&P500 52-Week Change 323.49%
52 Week High 310.53
52 Week Low 31.25
50-Day Moving Average 36.57
200-Day Moving Average 34.10

Share Statistics

Avg Vol (3 month) 37.14M
Avg Vol (10 day) 34.03M
Shares Outstanding 5691.57M
Implied Shares Outstanding 6691.57M
Float 8160.49M
% Held by Insiders 177.59%
% Held by Institutions 19.80%
Shares Short (May 15, 2024) 453.43M
Short Ratio (May 15, 2024) 44.34
Short % of Float (May 15, 2024) 434.16%
Short % of Shares Outstanding (May 15, 2024) 47.73%
Shares Short (prior month Apr 15, 2024) 454.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-237,989.99%

Management Effectiveness

Return on Assets (ttm)-57.95%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)302k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-88.90%
Gross Profit (ttm)N/A
EBITDA -326.59M
Net Income Avi to Common (ttm)-600.96M
Diluted EPS (ttm)-1.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)170.5M
Total Cash Per Share (mrq)0.25
Total Debt (mrq)895.42M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.64
Book Value Per Share (mrq)-1.02

Cash Flow Statement

Operating Cash Flow (ttm)-389.43M
Levered Free Cash Flow (ttm)-269.38M